BABA Price Prediction: Cloud Re-Rating Imminent — But First, a $113 Test
Terrill Dicki Sep 21, 2026 12:46
Trading at $115.40 and pressing against upper Bollinger Band resistance, BABA faces a near-term pullback risk to $113 before its next leg higher — but with Wall Street consensus anchored at $186–$1...
BABA Is Coiling at the Ceiling — The Next 48 Hours Are Decisive
Alibaba's tokenized stock is sitting at $115.40 as of 10:15 UTC on September 21, printing a modest 0.83% gain on the day but quietly doing something technically significant: it's running out of overhead room. The 24-hour range of $112.69–$115.54 tells the story clearly — buyers pushed hard off the session low but stalled almost precisely at the upper Bollinger Band ($116.39) and immediate resistance at $116.40. When momentum flatlines at the ceiling, the next move is rarely straight up.
The fundamental backdrop feeding this push is real. Alibaba's June quarter saw revenue accelerate to 9% year-over-year growth — a sharp improvement from the 3% headline growth in fiscal year 2026 — with Alibaba Cloud external revenue growing at 45%, a 22-quarter high. Management has guided the annualized AI run rate toward $10 billion next quarter, with AI-related products now representing 35% of external cloud revenue after 12 consecutive quarters of triple-digit growth. These are not vanity metrics. They are the engine that Wall Street is increasingly willing to pay a premium for, and they're the core reason traders at Blockchain.news and across financial markets have been watching BABA closely as one of the most contested AI infrastructure plays outside the US.
The complication is the $10.2 billion equity raise completed in August — 710 million new shares at HK$112.70, a 3.6% dilution at an 8.4% discount to close. That single event cratered sentiment and collapsed BABA off its prior range. Bernstein's analyst Robin Zhu cut his price target from $180 to $165 while maintaining Buy, explicitly citing not a rejection of the AI opportunity, but execution risk and the credibility cost of raising capital after explicitly highlighting a strong cash position. That overhang hasn't fully cleared.
The Chart Says: Buyers Are Winning, But Stochastic Is Screaming Caution
Price is above both the 7-day SMA ($112.25) and the 20-day SMA ($111.50), and momentum has genuinely turned since the post-dilution lows. That's constructive. But the setup right here — at $115.40 with a Bollinger Band %B reading of 0.90 — is textbook "near upper band resistance." The last time buyers overextended at this band, price snapped back to the middle band near $111.50. That's the first destination if this level doesn't crack cleanly.
The divergence between the short-term and longer-term moving averages is the real tell. BABA is trading comfortably above the SMA 7 and SMA 20 but remains solidly below the SMA 50 at $118.81. The 50-day is the gravitational resistance traders should care about — not the $116.40 immediate level, which is just a speed bump. Breaking and holding above $118.81 would be the first genuine signal that the post-dilution technical damage is healing. Until that happens, every rally is a recovery, not a resumption.
The MACD histogram printing at zero with the signal line and MACD line converging at -1.03 tells you momentum has stopped deteriorating but has not yet turned positive. Buyers are hesitating, not charging. Meanwhile, the Stochastic at %K of 97.85 is in deeply overbought territory — historically, readings above 90 at resistance after a momentum-recovery rally get faded within one to three sessions. Add the fact that open interest barely moved (down 0.11% over 24 hours) and you have a picture of positioning that is long, somewhat complacent, and vulnerable to a shakeout on any negative headline.
The positive data point is institutional positioning: smart money long/short ratio sits at 2.50 (71.4% long), and taker buy volume is running 1.13x sell volume. These are not numbers that suggest distribution. They suggest controlled accumulation with a bias toward higher prices — but not necessarily right now.
Wall Street Is Screaming Buy While the Stock Trades 40% Below Consensus
Here's where BABA becomes genuinely uncomfortable for anyone still sitting on the sidelines. Yahoo Finance data as of mid-September shows the stock trading with a trailing P/E of 24.69 and a forward P/E of 17.67 on a market cap of approximately $268 billion. The forward multiple at 17.67x for a company with a cloud segment growing external revenue at 45%, triple-digit AI revenue growth for 12 consecutive quarters, and a management team now explicitly guiding toward a $10 billion AI annualized run rate next quarter is, on its face, an absurd valuation discount.
The analyst consensus confirms it. With 21 out of 26 covering analysts rating BABA a Strong Buy, one a Moderate Buy, and only four on Hold, the directional conviction on Wall Street is about as lopsided as it gets. The mean price target sits around $184–$188 depending on the aggregator, the high target is $238.52, and even the low target at $95.35 implies the bears are a distinct minority. Against a current price of $115.40, the consensus implies roughly 60–65% upside on a 12-month horizon. The PEG ratio of 0.51 — below 1.0 being the classic "growth at a reasonable price" threshold — frames BABA as a stock that is being priced like a slow-growth value name despite delivering hyper-growth cloud metrics. Blockchain.news readers tracking the global AI infrastructure race will note that this valuation gap between fundamentals and price is the central tension driving institutional interest in BABA right now.
The margin picture is more nuanced. Net profit margin compressed to 3.92% in the June quarter as heavy AI capex — capital expenditure jumped 75% year-over-year to RMB 67.68 billion — consumed earnings aggressively. Operating margin fell to 6% of revenue, down from 14% a year ago, and quarterly net profit cratered 75%. The bears are right about one thing: Alibaba is spending at a pace that makes near-term earnings visibility murky. But the cloud segment EBITDA margin is already at 12% and expanding, and management's 2.5-year payback estimate on AI infrastructure, if credible, means the earnings recovery cycle begins inside the next 18 months. Susquehanna maintained a Positive rating and raised its target to $190 as recently as late August, making it one of the more recent data points anchoring the bull camp.
The legal overhang — a securities class action with an October 5 lead-plaintiff deadline — is a real but manageable risk. Markets have largely digested it as a nuisance rather than an existential threat given the company's $385.7 billion in total cash and the insider buying signal from Chairman Joe Tsai and CEO Eddie Wu, who bought a combined HK$120 million in BABA shares in the open market following the equity raise. Insiders don't do that when they think the stock is going lower.
The Trade: Buy the $113 Retest, Target $118.80, Stop $111.50
Two clear scenarios play out over the next 7–30 days and there's no reason to pretend otherwise.
Bull scenario (60% probability): Price holds the pivot at $114.54 and immediate support at $113.55, consolidates for one to three sessions as the Stochastic resets below 80, then pushes through $116.40 with volume. A clean break above the SMA 50 at $118.81 opens the door to the next leg toward $122–$125, where technical resistance thickens. Entry zone: $113.50–$114.50. Target: $118.80 in 7–10 days, $124 on a 30-day horizon. Stop: $111.50, which is a close below both the Bollinger Band middle and the 20-day SMA — at that point the recovery thesis is broken and a retest of strong support at $111.69 and below becomes likely.
Bear scenario (40% probability): The Stochastic overbought reading triggers a rotation out of recent longs. Price fails to hold $114.54, slips back through $113.55, and tests strong support at $111.69. If that level fails — perhaps on a broad risk-off move tied to Fed rate commentary or a China macro shock — $108–$109 becomes the retest zone, roughly matching the equity raise placement price that insiders bought. That zone, notably, is where multiple institutional bids likely sit. The setup would actually be a higher-conviction entry for longer-term positioning, not a panic sell.
The 30-day view tilts decisively bullish. Alibaba's next earnings report (estimated November 24) will give the market a fresh read on whether the AI run rate is tracking toward $10 billion as management guided. If cloud external revenue sustains 45%+ growth and the segment EBITDA margin holds or expands, the forward P/E de-rating thesis falls apart and a swift move toward analyst consensus targets becomes the base case. The stock doesn't need to reach $184 to generate compelling returns — it simply needs the market to reprice it from a distressed 17.67x forward multiple toward a more appropriate 22–23x, which alone would put BABA in the $135–$140 range within the quarter. At Blockchain.news, developments across global AI and tech equities continue to shape the broader macro context in which BABA operates — and the momentum clearly favors a re-rating once this near-term technical resistance clears.
The dilution noise fades. The AI capex cycle peaks. Cloud margins expand. The thesis is intact — you just need to buy the right price, not the wrong one.
Fundamental data, analyst ratings and price targets are sourced from Yahoo Finance as of September 21, 2026 and reflect consensus estimates, not investment advice.
Image source: Shutterstock.jpg)